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The human microbiome is overly exposed to antibiotics, due, not only to their medical
use, but also to their utilization in farm animals and crops. Microbiome composition
can be rapidly altered by exposure to antibiotics, with potential immediate effects
on health, for instance through the selection of resistant opportunistic pathogens
that can cause acute disease. Microbiome alterations induced by antibiotics can
also indirectly affect health in the long-term. The mutualistic microbes in the human
body interact with many physiological processes, and participate in the regulation of
immune andmetabolic homeostasis. Therefore, antibiotic exposure can alter many basic
physiological equilibria, promoting long-term disease. In addition, excessive antibiotic
use fosters bacterial resistance, and the overly exposed human microbiome has become
a significant reservoir of resistance genes, contributing to the increasing difficulty in
controlling bacterial infections. Here, the complex relationships between antibiotics and
the human microbiome are reviewed, with focus on the intestinal microbiota, addressing
(1) the effects of antibiotic use on the composition and function of the gut microbiota,
(2) the impact of antibiotic-induced microbiota alterations on immunity, metabolism, and
health, and (3) the role of the gut microbiota as a reservoir of antibiotic resistances.
Keywords: antibiotics, human gut microbiota, autoimmunity, immunotolerance, atopy, inflammation, dysbiosis,
resistance reservoir
EFFECTS OF ANTIBIOTICS ON THE GUT MICROBIOTA
Several lines of evidence conﬁrm that antibiotic administration can result in gut microbiota
dysbiosis, i.e., disturbance in composition and function. Broad-spectrum antibiotics can aﬀect the
abundances of 30% of the bacteria in the gut community, causing rapid and signiﬁcant drops in
taxonomic richness, diversity and evenness (Dethlefsen et al., 2008; Dethlefsen and Relman, 2011).
Once antibiotic treatment has stopped, the microbiota may present a certain degree of resilience,
being capable of returning to a composition similar to the original one, but the initial state is
often not totally recovered. In fact, antibiotic-induced microbiota alterations can remain after
long periods of time, spanning months and even years (De La Cochetiere et al., 2005; Jernberg
et al., 2007; Dethlefsen et al., 2008; Dethlefsen and Relman, 2011). In infants, few studies have
gaged the extent to which gut microbiota development is aﬀected by early exposure to antibiotics,
in spite of the major impact of this process on life-long health. Tanaka et al. (2009) and Fouhy
et al. (2012) studied the microbiota of infants treated with antibiotics in the ﬁrst days of life, and
reported eﬀects within 1 week and within 2 months after birth. Early antibiotic exposure both
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reduced the diversity of the infants’ microbiota and altered
its composition, with an attenuation of Biﬁdobacterium and
marked increases of Proteobacteria. Moreover, the microbiota of
those infants who were not treated, but whose mothers received
antibiotics prior to delivery, showed the same alterations seen in
the microbiota of the treated infants (Tanaka et al., 2009).
The impact of antibiotics on the gut microbiota has more
recently been investigated through the variety of “omic”
techniques available today for microbial community analyses
(reviewed in Franzosa et al., 2015). These works have shown that,
beyond altering the composition of taxa, antibiotics also aﬀect
the gene expression, protein activity and overall metabolism of
the gut microbiota. These changes can occur at a much faster
pace than those involving replacement of taxa in the community
(Perez-Cobas et al., 2012). Moreover, the induced changes can
drive the functionality of the microbiota toward states similar to
those observed under disease conditions. In this direction, the
microbiota of individuals treated with β-lactams has a repertoire
of enzymatic activities for carbohydrate degradation that results
in an unbalanced sugar metabolism, similar to that observed
in obese individuals (Hernandez et al., 2013). Experimental
approaches have also conﬁrmed that antibiotics rapidly alter
the physiological state and activity of the gut microbiota. In ex
vivo incubations of fecal samples with diﬀerent antibiotics, there
was an increase in the proportion of gut microbiota cells with
damaged membranes, the active populations of the microbiota
changed, and genes involved in antibiotic resistance, stress
response and phage induction augmented in expression (Maurice
et al., 2013). In addition, expression also increased for genes
related to genetic information processing (e.g., transcription and
translation) in the case of antibiotics that inhibit translation,
such as tetracycline and the macrolides. The substantial eﬀects
documented for antibiotics on the functioning of the gut
microbiota stress the likely impact that antibiotic exposure will
have on the physiological processes that depend on the activities
performed by the microbes in this community.
EFFECTS OF ANTIBIOTIC-INDUCED
MICROBIOTA ALTERATIONS ON
IMMUNE AND METABOLIC HEALTH
Increased Susceptibility to Infections
One of the most imminent threats of gut microbiota alterations
is the increased susceptibility to intestinal infections, which
can stem from newly acquired pathogens or from the sudden
overgrowth and pathogenic behavior of opportunistic organisms
already present in the microbiota. In particular, antibiotic-
associated diarrheas (AAD) due to nosocomial pathogens are a
frequent occurrence. These are often associated with organisms
such as Klebsiella pneumoniae, Staphylococcus aureus and, of
most concern, Clostridium diﬃcile, which can cause intractable,
long-term recurrent infections and even a potentially lethal
pseudomembranous colitis (Wilcox, 2003; Young and Schmidt,
2004; Song et al., 2008; Rupnik et al., 2009; Sekirov et al., 2010;
Chen et al., 2013). A mouse model has provided evidence that the
substantial losses of diversity caused by antibiotics in the small
and large intestinal microbiota can result in the establishment of a
chronic infection with C. diﬃcile (Lawley et al., 2009; Buﬃe et al.,
2012).
In addition, bloodstream infection in immunocompromised
individuals is another life-threatening condition that increases
in risk due to antibiotic treatment. In the clinical setting,
intestinal domination by vancomycin-resistant Enterococcus has
been shown to precede bloodstream infection by this pathogen,
and experimental work in mice has established that antibiotic
treatment sets the stage for the intestinal outgrowth of this
bacterium (Ubeda et al., 2010). In premature infants, who are
heavily treated with broad-spectrum antibiotics, the risk of sepsis
has also been related to gut microbiota composition and length of
antibiotic treatment (Madan et al., 2012; Mai et al., 2013).
Compromised Immune Homeostasis and
Tolerance
The microbiota alterations caused by antibiotics, beyond
increasing the immediate risk for infection, can also aﬀect
basic immune homeostasis with body-wide and long-term
repercussions. Atopic, inﬂammatory and autoimmune diseases
have been linked to gut microbiota dysbiosis, and, in some
cases, signiﬁcant associations have been established between these
diseases and the intake of antibiotics during early life. Clearly, the
eﬀects of antibiotic-induced dysbiosis will be even more relevant
if they occur early in life, a critical period for maturation of the
immune system and establishment of immunological tolerance
(Francino, 2014).
In the case of atopic diseases, numerous studies have
demonstrated links to the composition of the gut microbiota
during infancy and early childhood (Kuvaeva et al., 1984; Wold,
1998; Penders et al., 2006; Wang et al., 2008; Bisgaard et al.,
2011; Abrahamsson et al., 2012). Most recurrently, a signiﬁcant
association has been detected with biﬁdobacteria deﬁciency
(Sepp et al., 1997, 2005; Bjorksten et al., 1999; Kalliomaki
et al., 2001; Mah et al., 2006; Sjogren et al., 2009). However,
this link could not be upheld in two large prospective case-
control studies (Murray et al., 2005; Penders et al., 2006). As
not all Biﬁdobacterium species appear to have a protective role
(He et al., 2001; Ouwehand et al., 2001; Sjogren et al., 2009),
these discrepancies among studies could be due to the presence
of diﬀerent biﬁdobacteria in diﬀerent geographical regions, in
addition to the likely contribution of genetic variation among
human populations. On the other hand, high abundances of
organisms such as Clostridium coccoides and Escherichia coli
and a microbiota of low diversity have also been repeatedly
associated to the presence of diﬀerent atopic diseases (Bjorksten
et al., 2001; Sepp et al., 2005; Mah et al., 2006; Wang et al.,
2008; Bisgaard et al., 2011; Thompson-Chagoyan et al., 2011;
Abrahamsson et al., 2012). These associations suggest that early
antibiotic use would likely increase the risk for atopic disease, but
the existence of such link has been controversial (Bedford Russell
andMurch, 2006; Kuo et al., 2013). Retrospective epidemiological
studies have generally supported the association (Alm et al.,
1999; von Mutius et al., 1999; Wickens et al., 1999; Droste
et al., 2000; Wjst et al., 2001; Thomas et al., 2006; Foliaki
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et al., 2009), but most prospective analyses have failed to do
so (Illi et al., 2001; Celedon et al., 2002, 2004; Harris et al.,
2007; Wickens et al., 2008; Mai et al., 2010; Su et al., 2010).
Nevertheless, the application of techniques aimed at reducing
potential biases and confounding eﬀects has resulted in the
detection of dose-dependent associations between asthma and
early life exposure to antibiotics in several prospective studies
(McKeever et al., 2002; Kozyrskyj et al., 2007; Marra et al.,
2009). Moreover, broad-spectrum antibiotics show a stronger
association with asthma, indicating that a reduction of bacterial
diversity in the microbiota is likely to contribute to the eﬀect
of antibiotics on asthma development (McKeever et al., 2002;
Kozyrskyj et al., 2007). In addition to asthma, other allergic
outcomes have also recently been associated with early intake
of antibiotics (Risnes et al., 2011). Similarly, the risk for several
atopic diseases is increased by maternal intake of antibiotics
during pregnancy, in a dose-dependent manner (Jedrychowski
et al., 2006).
Gut microbiota composition has also been linked to
numerous disorders involving processes of inﬂammation and
autoimmunity. This is the case of necrotizing enterocolitis
(NEC), a devastating inﬂammatory disease for newborns. A low
abundance of Biﬁdobacterium, accompanied by a generally low
bacterial diversity, has been detected before NEC onset (Mai et al.,
2011, 2013). Morover, populations exposed to antibiotics, such
as preterm infants (Deshpande et al., 2010) and infants whose
mothers receive antibiotics in order to defer labor (Kenyon et al.,
2001), present an increased incidence of NEC. Chron’s disease
(CD), another inﬂammatory bowel disease (IBD), also increases
in those children who receive antibiotics before 5 years of age
(Hildebrand et al., 2008). This disease was one of the ﬁrst for
which an association with the human gut microbiota was clearly
established through metagenomic analyses, with a reduction in
Firmicutes (particularly C. leptum) and an increase of some
Gram−negative bacteria (Porﬁromonadaceae) often responsible
for inﬂammatory processes (Manichanh et al., 2006; Vanderploeg
et al., 2010). In the case of Irritable Bowel Syndrome (IBS),
which is the most common functional gastrointestinal disorder
in western countries, alterations in the gut microbiota have
also been detected (Vanner, 2008; Yamini and Pimentel, 2010;
Durban et al., 2012). Although no consensus has been reached
regarding the association between speciﬁc bacteria and IBS, the
gut microbiota of IBS patients has a reduced diversity. Moreover,
IBS often follows bouts of gastrointestinal infection and there
is evidence to suggest that antibiotics may play a role in the
pathogenesis of the disorder (Mendall and Kumar, 1998).
Deregulated Metabolism
Increasingly, the gut microbiota is being established as an
important factor in the regulation of host metabolism, in
particular as it relates to energy homeostasis and adiposity.
Several metabolic disorders have been linked with gut microbiota
dysbiosis. In particular, obesity has been associated with phylum-
level changes in the gut microbiota, reduced bacterial diversity,
and altered representation of bacterial genes and metabolic
pathways, diﬀerences that endow the obesity−associated
microbiota with an increased capacity to harvest energy from
the diet (Backhed et al., 2004; Turnbaugh et al., 2006, 2009). This
is in line with the fact that long-term exposure to antibiotics
is associated with increased body mass index, both in humans
(Thuny et al., 2010; Ajslev et al., 2011; Angelakis et al., 2012) and
in farm animals, where low-dose antibiotics have long been used
to promote weight gain (Burch, 1996). Moreover, recent work in
mice has shown that early antibiotic exposure can cause obesity
even with normal dietary intake (Cho et al., 2012). Antibiotic
use is therefore emerging as an important risk factor for the
development of obesity. In addition, it may also contribute to the
onset of metabolic syndrome in obese individuals. The metabolic
syndrome is a cluster of metabolic conditions that increase the
risk for cardiovascular disease, fatty liver disease, steatohepatitis
and type 2 diabetes. The advancement from obesity to metabolic
syndrome appears to involve the establishment of a state of
chronic low-grade inﬂammation, which could be exacerbated
by antibiotic use (Emanuela et al., 2012; Francino and Moya,
2013).
On the other hand, antibiotics have also recently been
implicated in increasing the risk for type 1, insulin-dependent
diabetes, an autoimmune disease whose incidence has been
steadily going up in industrialized countries in the last decades.
In an epidemiological study involving a large UK population,
the repeated use of penicillin, cephalosporins, macrolides, or
quinolones was associated with increase in diabetic risk (Boursi
et al., 2015). In a mouse model of type I diabetes, diﬀerent
antibiotic treatments that altered gut microbiota composition
were also shown to signiﬁcantly increase the incidence of the
disease (Candon et al., 2015).
THROUGH WHAT MECHANISMS DO
GUT MICROBIOTA ALTERATIONS
AFFECT IMMUNITY AND METABOLISM?
Besides their direct ecological eﬀects on the composition of
the gut microbiota, antibiotics aﬀect the manner in which
this community interacts with the host and regulates basic
physiological processes. Regarding the immune system’s capacity
to ﬁght infections, antibiotics indirectly alter the eﬀectiveness
of both innate and adaptive immune responses. As microbiota
composition changes, not only non-resistant organisms capable
of outcompeting potential pathogens are lost, but the altered
community will present a substantially diﬀerent repertoire
of microbial-associated molecular patterns (MAMPS) to the
receptors located in immune and epithelial cells. This will
result in an altered stimulation of receptors such as NOD1
and the Toll-like receptors (TLRs), which can cascade down
through a variety of immune processes, including lymphoid
tissue development, T cell diﬀerentiation, neutrophil priming,
production of antibacterials, and cytokine release (Ubeda and
Pamer, 2012). A series of experiments in mice have shown that
antibiotic treatment can reduce the capacity to ﬁght infections
by Gram-positive organisms by decreasing the expression of
bactericidal compounds and diminishing neutrophil-mediated
killing (Brandl et al., 2008; Vaishnava et al., 2008; Clarke
et al., 2010; Ubeda et al., 2010). In the case of the adaptive
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immune system, both the expression of Major Histocompatibility
Complex genes in the small and large intestine and the levels
of immunoglobulin G (IgG) in serum have been shown to
decrease in reponse to amoxicillin-induced gut microbiota
changes (Dufour et al., 2005).
On the other hand, the cellular and molecular mechanisms
by which gut microbiota alterations impact immunotolerance
have long been debated (Rautava et al., 2004; Romagnani, 2004;
Penders et al., 2007a; Sjogren et al., 2009; Jutel and Akdis, 2011).
The balance between the Th1 and Th2 helper cell subsets of the
adaptive immune system was, until recently, thought to be the
main condition required for maintaining immune homeostasis.
In support of this notion, chronic inﬂammatory/autoimmune
and allergic diseases are known to associate with excessive Th1
or Th2 activation, respectively (Abbas, 1996; Oboki et al., 2008).
Nevertheless, important roles for Th17 cells and regulatory T cells
(Tregs) have been demonstrated in diseases that had classically
been deﬁned as Th1 or Th2-mediated (Nakae et al., 2002;
Murphy, 2003; Oboki et al., 2008; Akdis and Akdis, 2009). In
the current view, it is a new cellular balance that is considered
critical for immune homeostasis: that between the Tregs and
their eﬀector cells, the diﬀerent Th subsets. Alterations of the
gut microbiota disrupt this balance, resulting in the deregulation
of immune responses that can promote a variety of disease
outcomes (Wills-Karp et al., 2001; Yazdanbakhsh et al., 2002;
Rautava et al., 2004; Rook and Brunet, 2005; Penders et al., 2007b;
Shen et al., 2014).
The generation of Tregs has indeed been shown to depend
on the crosstalk between the gut microbiota and the immune
system (Strauch et al., 2005). Experiments in mice or in in vitro
cell cultures have revealed diﬀerent speciﬁc bacteria and bacterial
products that are capable of Treg cell induction (Kline, 2007;
Baba et al., 2008). For instance, Bacteroides fragilis (Round
and Mazmanian, 2010) and Clostridium species belonging to
phylogenetic groups IV and XIV (Atarashi et al., 2011) promote
the diﬀerentiation of T cells into Tregs in mice. In contrast,
the Segmented Filamentous Bacteria (SFB) rather promote the
diﬀerentiation of pro-inﬂammatory Th17 cells (Ivanov et al.,
2009). This highlights the basic concept of diﬀerent microbes
driving the diﬀerentiation of naïve T cells into diﬀerent subtypes.
In humans, however, SFB are not commonly encountered in
the gut microbiota, and these bacteria probably do not play any
relevant role.
The routes through which antibiotic-induced microbiota
alterations disrupt the balance among T cells and disturb immune
homeostasis are being investigated in experimental mice models.
Vancomycin, which kills Gram-positive bacteria, has been shown
to cause a reduction of the number of Tregs in the lamina
propia of the colon and to impair the induction of Th17
cells (Atarashi et al., 2011). On the other hand, a cocktail of
antibiotics administered to two-week-old mice resulted in a
reduced expression of TLRs and cytokine proﬁles promoting
a Th2 response (Dimmitt et al., 2010). Similarly, kanamycin
administered to three-week-old mice resulted in reduction of
Peyer’s patch cellularity and in immune responses skewed
toward Th2. Importantly, subsequent colonization with diﬀerent
bacterial species had very diﬀerent eﬀects: Enterococcus faecalis
and Lactobacillus acidophilus reversed or attenuated the changes,
respectively, whereas Bacteroides vulgatus actually caused their
exacerbation. This underscores again the very diﬀerent roles that
speciﬁc types of bacteria play in relation to immune balance
(Sudo et al., 2002).
Antibiotic-induced dysbioses are also likely to inﬂuence
numerous immune and metabolic outcomes through routes that
aﬀect the intestinal milieu’s overall inﬂammatory tone. In this
regard, microbiota alterations can result in a decrease of IgA,
a non-inﬂammatory immunoglobulin involved in pathogen and
allergen exclusion (Rautava et al., 2004; Penders et al., 2007a;
Cerutti and Rescigno, 2008). In addition, metronidazole has been
shown to cause a decrease in the expression of Muc2, the major
component of the mucin layer (Wlodarska et al., 2011); thinning
of this layer would result in a more direct contact between
gut microbiota and epithelium, with likely increases in innate
immune stimulation and inﬂammation. Recent work in mice
has demonstrated that antibiotics can promote inﬂammation
by increasing translocation of native colonic bacteria across
the intestinal epithelium. Such translocation requires the
participation of both immune dendritic cells and colonic goblet
cells, and translocation enhancement results from the decrease
in microbial signals received by the goblet cells (Knoop et al.,
2015).
Inﬂammation-enhancing alterations in the gut microbiota,
such as can be produced by antibiotic exposure, are likely to play
a predominant role in the case of metabolic disorders such as
obesity, metabolic syndrome and diabetes. The microbiota has
been shown to contribute to the chronic low-grade inﬂammation
that is associated with an excess of adiposity and that likely
promotes the progression from obesity toward the metabolic
syndrome. In this respect, the microbiota alterations induced
by High Fat Diets (HFD) involve an increase of bacteria
containing lipopolysacharides (LPS) in the cell wall, resulting
in higher serum levels of this pro-inﬂammatory molecule, and
experiments mimicking the HFD state through continuous
subcutaneous infusion of LPS result in the induction of some
aspects of metabolic syndrome (Cani et al., 2007). A deﬁciency
in TLR5 also results in microbiota alterations that induce
metabolic syndrome conditions such as obesity, insulin resistance
and dyslipidemia. Moreover, the dysbiotic microbiota in itself
is capable of inducing these disorders, as they could be
reproduced in experiments in which the microbiota of TLR5-
deﬁcient mice was transplanted into germ-free recipients (Vijay-
Kumar et al., 2010). Inﬂammation was likely involved in the
onset of the observed metabolic conditions, as the wild-type
mice with the transplanted dysbiotic microbiota had higher
intestinal levels of the pro-inﬂammatory molecules TNFα and
IL-1β.
Another main route through which microbiota dysbioses will
induce their eﬀects on immunity and metabolism is likely to
be the alteration of short-chain fatty acids (SCFA) production.
Intestinal microbes consume non-digestible carbohydrates to
produce SCFAs, particularly acetate, propionate, and butyrate,
which are used locally by colonocytes or transported across
the gut epithelium into the bloodstream. SCFAs are major
players in the maintenance of gut physiology and integrity,
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promote immune andmetabolic homeostasis and have important
anti-inﬂammatory and antitumorigenic eﬀects (Bindels et al.,
2012; Tan et al., 2014). In particular, SCFAs interact with
G-protein-coupled receptors (GPCRs) to regulate fat deposition
(Samuel et al., 2008), and improve insulin secretion through
modulation of the levels of the GLP1 hormone (Tolhurst et al.,
2012). The speciﬁc composition of the microbiota alters the
types and levels of SCFA that can be formed, impinging on
numerous physiologic processes that are diﬀerentially aﬀected by
acetate, propionate, and butyrate (Macfarlane and Macfarlane,
2011). In addition to producing SCFAs, the gut microbiota is
responsible for converting the primary bile acids synthesized
in the human liver into secondary bile acids, also involved in
promoting glucose homeostasis through GPCR binding (Thomas
et al., 2009). Antibiotic-induced microbiota alterations have been
shown to alter bile acid metabolism and insulin sensitivity in both
humans and mice (Vrieze et al., 2014).
THE GUT MICROBIOTA AS RESERVOIR
OF ANTIBIOTIC RESISTANCES
The dysbioses brought about by antibiotics bear the added
disadvantage of enriching the microbiota in resistant organisms.
The human gut microbiota has been established as a signiﬁcant
reservoir of antibiotic resistances (Salyers et al., 2004; Seville et al.,
2009; Sommer et al., 2009; Ghosh et al., 2013; Moore et al., 2013;
Pehrsson et al., 2013; Card et al., 2014; Fouhy et al., 2014a,b;
Hu et al., 2014; Lu et al., 2014; von Wintersdorﬀ et al., 2014;
Clemente et al., 2015; Field and Hershberg, 2015). The scale of
the problem can be gaged by the fact that an analysis of 252
fecal metagenomes from diﬀerent countries identiﬁed resistance
genes for 50 out of the 68 antibiotic classes and subclasses
that were being screened for, with an average of 21 per sample
(Forslund et al., 2013). This study, the largest population-level
analysis of the intestinal resistome to date, also showed that the
abundance of antibiotic resistance genes (ARGs) is highest for
antibiotics that have been longer in the market and for those
approved for animal use, such as tetracycline, bacitracin and the
cephalosporins. Also, European samples showed enrichment in
resistances to vancomycin in comparison to samples from the
US, where an analog of vancomycin used to treat animals in
Europe was never employed. Moreover, the abundance of ARGs
was higher in samples from Southern Europe than in those
from Northern Europe, and correlated with measures of total
outpatient antibiotic use in the diﬀerent countries. This suite
of observations conﬁrms the notion that a higher exposure to
antibiotics increases the likelihood of resistance acquisition by the
gut microbiota.
Alarmingly, not only the microbiota of adults constitutes a
resistance reservoir, but children and infants also harbor a variety
of ARGs (Gueimonde et al., 2006; Mitsou et al., 2010; de Vries
et al., 2011; Zhang et al., 2011; Alicea-Serrano et al., 2013; Ghosh
et al., 2013; Field and Hershberg, 2015; Moore et al., 2015).
Recent analyses have shown that, in fact, numerous ARGs can
already be identiﬁed in feces of 1-week-old babies and even in
meconium, the ﬁrst deposition of newborns, which is formed by
material accumulated in the gastrointestinal tract during fetal life
(Gosalbes et al., 2015). Remarkably, ARGs are detected not only
in adults and children that have undergone antibiotic treatments,
but also in infants (Zhang et al., 2011; Fouhy et al., 2014a; Field
andHershberg, 2015; Gosalbes et al., 2015) and in isolated human
populations (Pallecchi et al., 2007; Clemente et al., 2015) that
have never been administered antibiotics. This indicates that
ARGs can be stably maintained in the human gut microbiome in
the absence of direct antibiotic selection, and is consistent with
the fact that ARGs can be detected in a large range of natural
environments, including those expected to have little exposure
to antibiotics derived from human usage (Field and Hershberg,
2015).
In the case of infants, resistances may be vertically inherited,
as maternal gut microbes can be transmitted to the oﬀspring
(Vaishampayan et al., 2010), with several lines of evidence
indicating that such transfer actually starts before birth (Jimenez
et al., 2005, 2008; Steel et al., 2005; DiGiulio et al., 2008; Gosalbes
et al., 2013, 2015; Aagaard et al., 2014). Several studies have
demonstrated shared ARG pools betweenmother and infant fecal
samples, and, in some cases, the presence of the shared ARGs in
meconium, colostrum or breast milk (de Vries et al., 2011; Zhang
et al., 2011; Gosalbes et al., 2015). Nevertheless, these studies
have also detected ARGs in infants that were not present in the
mothers and were most probably acquired from other sources.
Regarding remote human populations (Pallecchi et al., 2007;
Clemente et al., 2015), the presence of ARGs in their microbiotas
suggests two possibilities: (i) either their ARGs are ancestral
and were present before the rampant spread of resistance due
to human antibiotic use, presumably due to selective pressures
imposed by naturally occurring antibiotics, or (ii) they have been
acquired recently by dispersion of antibiotic resistant strains
from other areas and/or by horizontal transfer of genes from
such strains to their local bacterial populations. Phylogenetic and
population genetic analyses should be able to discern between
these alternatives.
Importantly, the human gut, given its enormous density of
bacterial cells and species richness, is likely to be especially prone
to horizontal gene exchange and to contribute to the spread
and reassortment of ARGs among bacterial taxa. Transfer of
ARGs between gut microbiota isolates of the genus Bacteroides,
as well as between Bacteroides and Gram-positive bacteria,
has been documented (Shoemaker et al., 2001). Identical ARG
sequences have actually been identiﬁed in bacteria coexisting
in the gut of a single individual, including diﬀerent strains of
E. coli (Karami et al., 2007) as well as distantly related organisms
(de Vries et al., 2011). Experimental work has conﬁrmed that
ARG-carrying transposons can be transferred between bacterial
species in the guts of rats and mice (Doucet-Populaire et al.,
1991; Alpert et al., 2003; Bahl et al., 2004). Furthermore, the
transfer of conjugative transposons can be stimulated 100- to
1000-fold by low concentrations of antibiotic (Whittle et al.,
2002). Of most concern, the ARGs present in the gut microbiota
can also be horizontally transferred from and to incoming
pathogenic species, as indicated by the fact that many of the
resistance genes identiﬁed in human gut isolates are identical at
the nucleotide level to resistance genes from human pathogenic
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FIGURE 1 | Antibiotic effects on the gut microbiota and associated health problems. The main biological consequences of antibiotic-induced dysbioses and
the potential diseases that can ensue from them are shown (only diseases with published evidence of association with antibiotic exposure are included). Involved
mechanisms are shown in pink-shaded boxes.
isolates (Sommer et al., 2009). Therefore, the human gut can
be considered, not only a site of accumulation of ARGs, but
also an environment where these genes can spread across species
boundaries.
SUMMARY AND OUTLOOK
It is clear that the excessively widespread use of antibiotics has
created many threats. These include the increasing resistance of
bacterial pathogens to antibiotics, which has become a global
challenge for infection control. But the eﬀects of excessive
antibiotic exposure can be seen, not only in pathogenic
bacteria, but also in the symbiotic microbiotas of the human
body (Francino and Moya, 2013). As a result, the microbiota
imbalances caused by antibiotics can negatively aﬀect health in
numerous manners and for long periods of time. The range of
problems potentially generated by antibiotic-induced microbiota
dysbioses, as reviewed in this paper, is summarized in Figure 1.
In light of this knowledge, and given that bacterial infections
remain a major public health concern, strategies are needed to
minimize the negative consequences of antibiotics when their
administration is required. Use of probiotic bacteria aimed at
impeding dysbiosis or at reestablishing the gut microbiota after
antibiotic treatment is a promising approach. On the other hand,
strategies could also be aimed at reestablishing the interactions
altered by antibiotic treatment through the targeted use of
bacterial molecules that bind speciﬁc innate immune receptors
(Ubeda and Pamer, 2012). Much further research is needed
to delineate the best manners in which bacteria and bacterial
products can be employed to counteract the deleterious eﬀects
of antibiotics on the gut microbiota and its multiple interactions
with immunity and metabolism.
An equally important line of research should aim at
understanding the patterns of dispersion and expansion of
antibiotic resistant strains in the human gut microbiome, as well
as the routes of gene exchange that may distribute resistances
across diﬀerent gut taxa. Virome and mobilome analyses should
enable us to establish the associations of ARGs with speciﬁc
genetic elements, providing clues to the paths through which
they can be disseminated within and across gut microbial
communities. Understanding the ﬂow of resistances within the
gut microbiome will contribute an important piece to the puzzle
of antibiotic resistance epidemiology, which needs to integrate
information from human and environmental microbiomes to the
analysis of resistance spread in pathogenic isolates.
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